Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
DHR Danaher Corporation daily Stock Chart
DHR [NYSE]
Danaher Corporation
Industrial Goods | Diversified Machinery | USA
financial highlights | statements
IndexS&P 500 P/E34.81 EPS (ttm)3.73 Insider Own0.60% Shs Outstand726.77M Perf Week0.78%
Market Cap94.25B Forward P/E24.64 EPS next Y5.26 Insider Trans-8.30% Shs Float630.81M Perf Month15.35%
Income2.64B PEG5.15 EPS next Q1.01 Inst Own80.40% Short Float0.76% Perf Quarter28.85%
Sales19.89B P/S4.74 EPS this Y6.40% Inst Trans1.53% Short Ratio1.57 Perf Half Y20.63%
Book/sh40.19 P/B3.23 EPS next Y9.78% ROA5.60% Target Price130.50 Perf Year29.94%
Cash/sh1.08 P/C119.64 EPS next 5Y6.77% ROE9.60% 52W Range94.59 - 132.43 Perf YTD25.77%
Dividend0.68 P/FCF32.14 EPS past 5Y0.40% ROI7.30% 52W High-2.07% Beta1.05
Dividend %0.52% Quick Ratio1.10 Sales past 5Y1.70% Gross Margin55.80% 52W Low37.11% ATR2.07
Employees71000 Current Ratio1.50 Sales Q/Q5.50% Oper. Margin17.10% RSI (14)69.70 Volatility1.72% 1.51%
OptionableYes Debt/Eq0.35 EPS Q/Q-14.00% Profit Margin13.30% Rel Volume0.96 Prev Close132.29
ShortableYes LT Debt/Eq0.34 EarningsJan 29 BMO Payout16.40% Avg Volume3.07M Price129.69
Recom1.60 SMA202.72% SMA5012.41% SMA20022.87% Volume2,940,265 Change-1.97%
Feb-28-19Reiterated Needham Buy $114 → $138
Feb-25-19Upgrade Janney Neutral → Buy
Jan-03-19Initiated Needham Buy $114
Apr-20-18Reiterated Stifel Buy $108 → $114
Feb-15-18Initiated Barclays Overweight $110
Sep-26-17Resumed Goldman Neutral $83
Jul-13-17Initiated Wells Fargo Market Perform
Jun-07-17Downgrade Janney Buy → Neutral
Apr-21-17Reiterated RBC Capital Mkts Sector Perform $89 → $88
Feb-24-17Upgrade Citigroup Neutral → Buy
Feb-01-17Initiated Credit Suisse Outperform $93
Jan-18-17Initiated Deutsche Bank Buy $88
Dec-13-16Resumed Morgan Stanley Overweight
Jul-11-16Reiterated Barclays Overweight $105 → $86
Jul-05-16Initiated Goldman Neutral
Jun-24-16Upgrade Bernstein Mkt Perform → Outperform
May-27-16Reiterated RBC Capital Mkts Sector Perform $96 → $99
Apr-22-16Reiterated Stifel Buy $109 → $110
Apr-22-16Reiterated RBC Capital Mkts Sector Perform $87 → $96
Apr-22-16Reiterated Barclays Overweight $104 → $105
Mar-24-19 12:14PM  3 Stocks Looking to Benefit From GE's Misfortunes Motley Fool
Mar-20-19 07:12AM  This Rally in General Electric Stock Isnt Totally Irrational InvestorPlace
Mar-19-19 04:15PM  Danaher Schedules First Quarter 2019 Earnings Conference Call PR Newswire
09:30AM  UTX vs. DHR: Which Stock Should Value Investors Buy Now? Zacks
Mar-18-19 09:57AM  General Electric should make this major change, once and for all Yahoo Finance
09:05AM  Danaher to Gain From Solid Demand in Key Markets Amid Risks Zacks
Mar-11-19 05:01AM  Too Early or Too Late? General Electric Stock Has Investors Guessing InvestorPlace
Mar-08-19 04:15PM  Danaher Announces Quarterly Dividend PR Newswire
08:00AM  What the GE-Danaher Deal Means to Both Sets of Investors Motley Fool
Mar-06-19 10:44PM  [$$] The Investors Who Bet Big on GE The Wall Street Journal
11:45AM  [$$] Investors Who Bet Big on GE The Wall Street Journal
11:31AM  Has the Turnaround of GE Stock Already Come and Gone? InvestorPlace
09:27AM  GE's stock tumbles again after downbeat cash flow outlook and analyst call MarketWatch
08:20AM  Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics Future Expectations, Projections Moving into 2019 GlobeNewswire
Mar-05-19 02:02PM  GE Stock Drops After CEO Steps Into the Bear Pit Barrons.com
08:07AM  How Corporate America's New Debt Diet Will Boost Stocks Investopedia
Mar-04-19 03:13PM  Healthcare ETF Keeps Hitting New Highs ETF Trends
10:30AM  GE Stock Could Almost Double to $20, Says Analyst Barrons.com
08:53AM  Will Danaher Corporations (NYSE:DHR) Earnings Grow In The Next 12 Months? Simply Wall St.
07:18AM  Danaher's Stock Offering Proceeds to Fund BioPharma Buyout Zacks
Mar-01-19 05:00PM  Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering PR Newswire
04:00PM  GE Nuggets to Chew on From Its Annual Report Bloomberg
Feb-28-19 12:45PM  GE's stock sinks to pace industrial sector's losers; set to snap 4-day win streak MarketWatch
11:08AM  Is Larry Culp Leading General Electric In the Right Direction? InvestorPlace
08:24AM  GE Intends to Lower Debt Burden, Boost Dividend Payments Zacks
Feb-27-19 12:15PM  An Influential Analyst Finds GEs Newest Deal Uninspiring Barrons.com
09:48AM  General Electric Biopharma Sale Helps Debt Reduction, Hurts Earnings - JPM Tusa TheStreet.com
05:29AM  Health care is once again part of GEs future, Culp tells investors American City Business Journals
Feb-26-19 11:15PM  Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering PR Newswire
10:54AM  GE shares jump again as Wall Street loves Danaher deal: Stock no longer has 'downside risk' CNBC
09:49AM  Danaher to Buy BioPharma, Offers Common & Preferred Shares Zacks
09:47AM  General Electric (GE) to Divest BioPharma, Closes Wabtec Deal Zacks
09:30AM  Company News For Feb 26, 2019 Zacks
09:13AM  Tuesdays Vital Data: General Electric, Alibaba and Cisco InvestorPlace
08:54AM  Danaher (DHR) Catches Eye: Stock Jumps 8.5% Zacks
07:12AM  How General Electric and Danaher Created $16 Billion in Market Value With Just One Deal Barrons.com
Feb-25-19 08:02PM  Has General Electric Officially Turned the Corner? Motley Fool +8.52%
07:50PM  [$$] GE to Sell Its Biotech Business to Danaher for $21 Billion The Wall Street Journal
07:26PM  GE's Big Debt Problem Just Disappeared Motley Fool
05:48PM  Mario Gabelli's take on today's flurry of M&A activity CNBC Videos
05:12PM  Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock PR Newswire
04:31PM  Why Danaher, CRISPR Therapeutics, and Clementia Pharmaceuticals Jumped Today Motley Fool
04:25PM  GE Surges After Agreeing to $21.4 Billion Sale of BioPharma Unit Bloomberg
04:08PM  Danaher To Buy GE Biopharma For $21.4 Billion But A Key IPO Is Now In Doubt Investor's Business Daily
04:06PM  Dow Closes Modestly Higher After Trump Extends China Tariff Deadline TheStreet.com
03:59PM  5 Top Stock Trades for Tuesday: S&P 500, Amazon and Danaher InvestorPlace
03:15PM  GE Puts Debt Cuts in Forefront With $21 Billion Asset Sale Bloomberg
02:50PM  GE inks $21 billion biopharma sale to Danaher in U-turn under Culp Reuters
02:39PM  GE inks $21 billion biopharma sale to Danaher in U-turn under Culp Reuters
01:55PM  Pre-Markets Up, GE Sells Off Biopharma Biz Zacks
01:46PM  GE debt rallies, bond insurance price drops on Danaher deal Reuters
12:46PM  [$$] GE to Sell Its Biotech Business to Danaher for $21 Billion The Wall Street Journal
12:19PM  GE Healthcare spinoff likely shelved for 2019 American City Business Journals
12:18PM  Danaher Stock Surges on GE Biopharma Deal InvestorPlace
12:14PM  Why General Electric Stock Popped 15% This Morning Motley Fool
11:46AM  Danaher's credit rating could be cut more than 1 notch after GE biopharma deal--Moody's MarketWatch
11:42AM  Stock Market News: Barrick Gold Gets Hostile, GE Soars Motley Fool
11:26AM  Danaher acquires GE biopharma business for $21.4B American City Business Journals
10:49AM  Danaher Luxembourg Finance S.A. -- Moody's places ratings of Danaher on review for downgrade following announcement of plan to acquire certain of GE's biologics businesses Moody's
10:45AM  Bodenholm Capitals Returns, AUM and Holdings Insider Monkey
10:19AM  Positive Development on Trade War Front Zacks
10:12AM  GE Soars on `Favorable' Deal as Street Awaits Power Plan Bloomberg
10:05AM  Pre-Markets Up, GE Sells Off Biopharma Biz Zacks
09:48AM  Danaher to IPO dental unit after $21.4 billion deal to buy GE's biopharma business Reuters
09:48AM  GE CEO Larry Culp: Danaher deal is the superior path to a health-care IPO CNBC Videos
09:42AM  Danaher to IPO dental unit after $21.4 bln deal to buy GE's biopharma business Reuters
09:36AM  GE Deal With Danaher Shows Culp Is All About the Balance Sheet Bloomberg
09:32AM  GE chief Culp sells biopharma business for $21.4 billion Reuters
09:23AM  GE credit rating won't change after $21 billion deal to sell biopharma business--S&P Global MarketWatch
08:44AM  In $21B deal, GE to sell life sciences business to Culps old firm American City Business Journals
08:30AM  GE sells biopharma unit for $21 billion Associated Press
07:59AM  [$$] FirstFT: Todays top stories Financial Times
07:27AM  [$$] General Electric to sell slice of life sciences unit in $21bn deal Financial Times
07:15AM  GE's stock soars after deal to sell biopharma business to Danaher for $21.4 billion MarketWatch
07:02AM  GE shares surge 17% after Danaher agrees to buy biopharma business for $21.4 billion CNBC
07:00AM  Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion PR Newswire
Feb-18-19 08:36AM  Why You Should Care About Danaher Corporations (NYSE:DHR) Low Return On Capital Simply Wall St.
Feb-16-19 08:17AM  Is Danaher Stock Still a Good Investment? Motley Fool
Feb-14-19 10:50AM  The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia Zacks
10:21AM  As Culp Cleans Up, Heres the Speculative Buy Case for GE Stock InvestorPlace
Feb-13-19 04:15PM  Danaher To Present At Barclays Industrial Select Conference PR Newswire
01:37PM  Top Research Reports for ExxonMobil, Merck & Danaher Zacks
Feb-12-19 09:30AM  CSL or DHR: Which Is the Better Value Stock Right Now? Zacks
Feb-11-19 02:03PM  The Easy Gains for General Electric Stock May Be Over InvestorPlace
Feb-08-19 02:31PM  General Electric Stock Has Rallied Too Far, Too Fast InvestorPlace
Feb-01-19 01:54PM  DH Switzerland Finance S.A. -- Moody's affirms Danaher's ratings; senior unsecured at A2 and short-term at P-1; outlook stable Moody's
Jan-31-19 10:19AM  3 Pros, 3 Cons of General Electric Stock InvestorPlace
07:33AM  Do Institutions Own Danaher Corporation (NYSE:DHR) Shares? Simply Wall St.
07:30AM  Investor Expectations to Drive Momentum within E*TRADE Financial, Alliant Energy, DENTSPLY SIRONA, Danaher, Aspen Technology, and Marin Software Discovering Underlying Factors of Influence GlobeNewswire
Jan-30-19 04:33PM  Earnings Report Brings Brighter Smiles to Align Stock Investors InvestorPlace
04:30AM  Edited Transcript of DHR earnings conference call or presentation 29-Jan-19 1:00pm GMT Thomson Reuters StreetEvents
Jan-29-19 04:57PM  3 Stocks Move Tuesday GuruFocus.com
04:24PM  Danaher Posts Slight Fourth-Quarter Earnings Beat TheStreet.com
02:03PM  3M Cut Its Guidance. This Is Why Its Stock Is Gaining Barrons.com
02:00PM  Danaher Corp (DHR) Q4 2018 Earnings Conference Call Transcript Motley Fool
11:39AM  Danaher (DHR) Q4 Earnings & Revenues Beat Estimates, Up Y/Y Zacks
08:10AM  Danaher (DHR) Q4 Earnings and Revenues Beat Estimates Zacks
06:58AM  [$$] Danaher's Profit Falls As Costs Rise The Wall Street Journal
06:19AM  Danaher: 4Q Earnings Snapshot Associated Press
06:00AM  Danaher Reports Fourth Quarter And Full Year 2018 Results PR Newswire
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company's Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides analytical instruments, software, services, and consumables for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 27Option Exercise32.8730,000986,10037,251Feb 28 05:19 PM
Raskas DanielSVP-Corporate DevelopmentFeb 27Option Exercise28.2338,9551,099,70066,079Feb 28 05:21 PM
Blair RainerExecutive Vice PresidentFeb 27Option Exercise49.1520,7991,022,17546,333Feb 28 05:13 PM
SCHWIETERS JOHN TDirectorFeb 27Option Exercise23.3910,578247,41928,693Feb 28 05:22 PM
COMAS DANIEL LEVPFeb 27Option Exercise40.4585,3863,453,864219,425Feb 28 05:14 PM
LOHR WALTER GDirectorFeb 27Option Exercise23.3910,578247,41920,691Feb 28 05:18 PM
Lalor Angela SSVP, Human ResourcesFeb 27Sale127.254,534576,94744,494Feb 28 05:17 PM
Ellis Brian WSenior Vice President - GCFeb 27Sale127.221,564198,97721,209Feb 28 05:15 PM
Blair RainerExecutive Vice PresidentFeb 27Sale127.4537,8594,825,10532,661Feb 28 05:13 PM
Raskas DanielSVP-Corporate DevelopmentFeb 27Sale126.4549,1646,216,66225,941Feb 28 05:21 PM
SCHWIETERS JOHN TDirectorFeb 27Sale126.8110,5781,341,34318,115Feb 28 05:22 PM
COMAS DANIEL LEVPFeb 27Sale127.0497,35712,368,003134,039Feb 28 05:14 PM
LOHR WALTER GDirectorFeb 27Sale126.8510,5781,341,84010,113Feb 28 05:18 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 27Sale126.9517,8222,262,45322,251Feb 28 05:19 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerFeb 24Sale127.0015,0001,904,92522,251Feb 28 05:19 PM
COMAS DANIEL LEVP & CFONov 08Option Exercise40.4525,0001,011,250149,218Nov 09 05:23 PM
COMAS DANIEL LEVP & CFONov 08Sale104.6125,0002,615,225124,218Nov 09 05:23 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerNov 07Option Exercise28.2315,000423,45033,044Nov 09 05:24 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerNov 07Sale103.8015,0001,556,97018,044Nov 09 05:24 PM
COMAS DANIEL LEVP & CFONov 07Sale102.2111,0001,124,299124,218Nov 09 05:23 PM
Joyce Thomas Patrick JRPresident and CEONov 07Sale103.895,212541,464151,829Nov 09 05:12 PM
King WilliamSenior Vice PresidentNov 05Option Exercise36.4953,4331,949,74252,028Nov 06 05:22 PM
King WilliamSenior Vice PresidentNov 05Sale101.6453,4335,430,73923,017Nov 06 05:22 PM
DANIEL WILLIAM KEVPOct 25Sale98.0022,7212,226,658119,171Oct 26 05:13 PM
DANIEL WILLIAM KEVPOct 24Sale98.157,063693,241141,892Oct 26 05:13 PM
EHRLICH DONALD JDirectorOct 23Option Exercise23.3910,578247,419105,491Oct 25 05:12 PM
EHRLICH DONALD JDirectorOct 23Sale95.7710,5781,013,08794,913Oct 25 05:12 PM
DANIEL WILLIAM KEVPAug 10Option Exercise28.2384,9612,398,449202,328Aug 13 05:12 PM
DANIEL WILLIAM KEVPAug 10Sale100.3884,9618,528,221148,955Aug 13 05:12 PM
DANIEL WILLIAM KEVPAug 09Option Exercise28.2318,125511,669167,080Aug 13 05:12 PM
DANIEL WILLIAM KEVPAug 09Sale101.8418,1251,845,832148,955Aug 13 05:12 PM
RALES MITCHELL PChairman of Exec. CommitteeJul 31Buy102.321,080110,50625,660Aug 01 04:11 PM
Joyce Thomas Patrick JRPresident and CEOJul 31Sale102.1510,2891,051,052161,912Aug 01 05:13 PM
Joyce Thomas Patrick JRPresident and CEOJul 30Option Exercise40.4594,6243,827,541276,438Aug 01 05:13 PM
Joyce Thomas Patrick JRPresident and CEOJul 30Sale101.8594,6249,637,454181,814Aug 01 05:13 PM
COMAS DANIEL LEVP & CFOJul 26Option Exercise37.5159,4302,229,219194,648Jul 30 05:12 PM
COMAS DANIEL LEVP & CFOJul 26Sale103.9377,4078,044,778135,218Jul 30 05:12 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerJul 24Option Exercise28.238,955252,80026,999Jul 25 05:19 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerJul 24Sale103.9314,5551,512,63718,044Jul 25 05:19 PM
Lalor Angela SSVP, Human ResourcesJul 23Sale102.729,074932,09936,408Jul 25 05:20 PM
HEFNER LINDA PDirectorApr 26Option Exercise30.1210,578318,60935,803Apr 30 05:11 PM
HEFNER LINDA PDirectorApr 26Sale101.5118,0011,827,19725,225Apr 30 05:11 PM
COMAS DANIEL LEVP & CFOApr 23Option Exercise37.5153,1731,994,519201,942Apr 24 05:41 PM
COMAS DANIEL LEVP & CFOApr 23Sale101.8053,1735,413,011148,769Apr 24 05:41 PM
Joyce Thomas Patrick JRPresident and CEOApr 20Option Exercise37.51102,3723,839,974254,331Apr 24 05:40 PM
COMAS DANIEL LEVP & CFOApr 20Option Exercise37.516,827256,081155,596Apr 24 05:41 PM
COMAS DANIEL LEVP & CFOApr 20Sale101.3925,2062,555,723148,769Apr 24 05:41 PM
Joyce Thomas Patrick JRPresident and CEOApr 20Sale101.17120,35412,176,176151,959Apr 24 05:40 PM
open in yahoo | open in reuters | open in google